Caliper validation of the submitted claim (drug=ozanimod, AE=Bradycardia). BELOW_PRR_THRESHOLD — disproportionality not significant (PRR=0.83, lower CI=0.54)
BELOW_PRR_THRESHOLD — disproportionality not significant (PRR=0.83, lower CI=0.54)| MedDRA PT | n |
|---|---|
| Bradycardia | 20 |
| Dizziness | 4 |
| Headache | 2 |
| Vision blurred | 2 |
| Abdominal pain | 1 |
| Asthenia | 1 |
| Blood pressure decreased | 1 |
| COVID-19 | 1 |
Every finding includes an in-engine adversary review at no cost. For findings you plan to cite in a regulatory submission, scientific publication, or board-grade decision, we offer an additional layer of independent, audit-grade verification — reviewed by an externally-trained system that has never seen your data, your training corpus, or our hardware, and cryptographically signed.
Contact us for verification & validation →505f7700db29c8bfe3de343bae6d7bff6e88ee0b